United States
Machine Bio is an early stage biotechnology company founded in 2018. The company's slogan -"Machine Bio is a biotech company offering unique protein synthesis and purification solutions"- succinctly encapsulates its focus. Machine Bio is developing a novel, proprietary protein synthesis platform that enables the efficient production of pure protein from a DNA template in a simple single-step, 4-hour process.
This breakthrough technology holds the potential for widespread impact as proteins are extensively used across various industries. The applications of Machine Bio's platform span drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing.
Currently, there is no information available regarding headquarters location, last investment, or the investors involved in the last investment. However, with its innovative approach to protein synthesis and purification, Machine Bio presents an intriguing investment opportunity in the biotechnology sector.
